Neural effects of the CSMD1 genome-wide associated schizophrenia risk variant rs10503253

ABSTRACT The single nucleotide polymorphism rs10503253 within the CUB and Sushi multiple domains‐1 (CSMD1) gene on 8p23.2 has been identified as genome‐wide significant for schizophrenia (SZ). This gene is of unknown function but has been implicated in multiple neurodevelopmental disorders that impa...

Full description

Saved in:
Bibliographic Details
Published in:American journal of medical genetics. Part B, Neuropsychiatric genetics Vol. 162B; no. 6; pp. 530 - 537
Main Authors: Rose, Emma J., Morris, Derek W., Hargreaves, April, Fahey, Ciara, Greene, Ciara, Garavan, Hugh, Gill, Michael, Corvin, Aiden, Donohoe, Gary
Format: Journal Article
Language:English
Published: United States Blackwell Publishing Ltd 01-09-2013
Wiley Subscription Services, Inc
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:ABSTRACT The single nucleotide polymorphism rs10503253 within the CUB and Sushi multiple domains‐1 (CSMD1) gene on 8p23.2 has been identified as genome‐wide significant for schizophrenia (SZ). This gene is of unknown function but has been implicated in multiple neurodevelopmental disorders that impact upon cognition, leading us to hypothesize that an effect on brain structure and function underlying cognitive processes may be part of the mechanism by which CMSD1 increases illness risk. To test this hypothesis, we investigated this CSMD1 variant in vivo in healthy participants in a magnetic resonance imaging (MRI) study comprised of both fMRI of spatial working memory (N = 50) and a voxel‐based morphometry investigation of grey and white matter (WM) volume (N = 150). Analyses of these data indicated that the risk “A” allele was associated with comparatively reduced cortical activations in BA18, that is, middle occipital gyrus and cuneus; posterior brain regions that support maintenance processes during performance of a spatial working memory task. Conversely, there was an absence of significant structural differences in brain volume (i.e., grey or WM). In accordance with previous evidence, these data suggest that CSMD1 may mediate brain function related to cognitive processes (i.e., executive function); with the relatively deleterious effects of the identified “A” risk allele on brain activity possibly constituting part of the mechanism by which CSMD1 increases schizophrenia risk. © 2013 Wiley Periodicals, Inc.
Bibliography:Wellcome Trust and Science Foundation Ireland (SFI)
istex:BB7A104F31BA3CEC47FEBBF13040C1D4B8FFD640
ArticleID:AJMGB32182
HRB Research Project Grant
All authors confirm that they have no conflict of interest in relation to this manuscript.
ark:/67375/WNG-3D95TWLH-5
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ObjectType-Article-2
ObjectType-Feature-1
ISSN:1552-4841
1552-485X
DOI:10.1002/ajmg.b.32182